V

Valeris

Biopharma commercialization and patient support

Director Pharmacy

Full-Time
No salary listed
Senior
Bachelor's, PharmD
Scottsdale, AZ, USA
In Person

About the job

Requirements
  • A Doctor of Pharmacy or Bachelor's in Pharmacy from an accredited school of pharmacy is required.
  • An active and unrestricted pharmacist license in good standing in Arizona is required, with the ability to obtain licensure in additional states as required for business needs.
  • A minimum of 5–8 years of experience in specialty or mail-order pharmacy operations is required.
  • A minimum of 2–5 years of management experience overseeing at least three direct or indirect reports is required.
  • Knowledge of pharmacy regulations, accreditation standards, company policies, HIPAA requirements, and quality assurance initiatives is required.
Responsibilities
  • Provide leadership and oversight for pharmacy technician operational teams through direct management of supervisors and managers responsible for front-end and back-end pharmacy operations.
  • Drive operational excellence initiatives focused on patient safety, prescription accuracy, workflow optimization, fulfillment efficiency, quality outcomes, and speed to therapy.
  • Collaborate with pharmacy leadership to establish, communicate, and execute aligned operational goals and performance expectations across pharmacy operational areas.
  • Develop, monitor, and analyze operational metrics, key performance indicators, productivity standards, turnaround times, fulfillment performance, and service level outcomes.
  • Partner with the director of compliance and regulatory affairs to ensure compliance with pharmacy regulations, accreditation standards, company policies, HIPAA requirements, and quality assurance initiatives.
  • Lead workforce planning activities to ensure appropriate staffing levels, productivity standards, and operational efficiency across departments.
  • Promote employee engagement, professional development, coaching, succession planning, and leadership growth across operational teams.
  • Partner with internal departments and cross-functional teams to improve communication, coordination, and overall program effectiveness.
  • Develop and maintain working relationships and strategic partnerships with external clients, vendors, manufacturers, and program stakeholders.
  • Identify operational risks and implement process improvements to enhance service delivery, patient experience, fulfillment accuracy, and business performance.
  • Support escalated operational, fulfillment, and customer service issues while ensuring timely resolution and service recovery.
  • Participate in strategic planning initiatives and organizational growth activities.
  • Assist with implementation of new programs, technologies, workflows, automation initiatives, and operational enhancements.
  • Support audit preparation, accreditation activities, and regulatory inspections as needed.
  • Contribute to budget planning, resource allocation, and cost management initiatives.
  • Represent pharmacy operations in leadership meetings, client discussions, and cross-functional committees.
  • Maintain current knowledge of industry trends, specialty pharmacy operations, fulfillment best practices, and regulatory updates.
  • Perform additional duties and special projects as assigned.
Desired Qualifications
  • Doctor of Pharmacy degree is preferred.
  • Additional non-resident state pharmacist licenses are preferred for business continuity.
  • Flexibility to travel as needed is preferred.
  • Candidates who can type at least 35 words per minute with 97% accuracy are preferred.

About the company

Valeris delivers end-to-end life sciences commercialization support for biopharmaceuticals, spanning strategy, patient access, and provider engagement. Its platform combines patient access and affordability programs, payer reimbursement support, data insights, and clinician engagement tools to streamline the patient journey. By integrating PharmaCord’s patient services with Mercalis’s technology and market access infrastructure, Valeris positions itself as an independent, scalable partner in patient access and support. Backed by Permira and Odyssey Investment Partners, Valeris helps clients navigate market access, speed therapy adoption, improve patient outcomes, and generate actionable commercialization insights.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Get referred to Valeris

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • January 20, 2026 results said Valeris exceeded fiscal 2025 goals after the merger.
  • July 27, 2026, SaveOn SP removed several brands, restoring full copay value.
  • April 29, 2026 Fuze Health collaboration expands digital pharmacy and access workflows.

What critics are saying

  • Payers keep deploying medical benefit maximizers; Valeris named 200 targeted brands on Policy Reporter.
  • Vantage centralizes PHI, creating HIPAA breach and model-error liability during 2026 rollouts.
  • Integration can stall service quality, and lost manufacturer contracts would crush the merged platform.

What makes Valeris unique

  • Valeris combines Mercalis market access with PharmaCord patient support across 500-plus biopharma customers.
  • Its June 16, 2026 Vantage platform adds real-time compliance guidance and 100% interaction QA.
  • Lauren Cole and Jeff Crowther strengthen strategy and revenue execution under Scott Filosi.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Life Insurance

Disability Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Company News

PR Newswire
Sep 15th, 2026
Valeris hires Jeff Crowther as Chief Revenue Officer to drive growth strategy

Valeris, a life sciences commercialisation partner, has appointed Jeff Crowther as Chief Revenue Officer. Crowther brings over 30 years of commercial leadership experience across marketing, sales, market access, and business development, with expertise spanning oncology, hematology, CNS, gastroenterology, and infectious diseases. He joins from Syndax Pharmaceuticals, where he served as SVP, Commercial, building the oncology biotech's inaugural commercial functions ahead of its first two asset launches. Previously, at SK Life Science, Crowther built the commercial infrastructure behind XCOPRI, the most successful adult partial-onset seizure product launch in the US in over a decade. Crowther will report to Chief Commercial Officer Scott Filosi and join the Valeris Executive Committee. The appointment reflects Valeris's continued investment in growth and innovation whilst maintaining focus on patient-centred strategic decisions.

PR Newswire
Aug 18th, 2026
Valeris appoints Lauren Cole as chief strategy officer to strengthen patient services integration

Valeris, a commercialisation partner for life sciences companies, has appointed Lauren Cole as Chief Strategy Officer. Cole will report to Chief Commercial Officer Scott Filosi and focus on integrating market access, patient services, and commercial strategy. Cole brings extensive experience in patient services and market access strategy. Most recently, she served as Vice President of Patient Services at Verona Pharma, a Merck subsidiary, where she led a patient services unit that improved access outcomes. Previously, she held the position of Executive Director of Patient Services at Ardelyx, designing patient services solutions for nephrology medications. Valeris provides commercialisation solutions to over 500 life sciences customers and has supported millions of patients with access and affordability programmes.

PR Newswire
Jun 16th, 2026
Valeris launches Vantage™ platform to help patient support teams navigate complex therapy journeys in real time

Valeris, a life sciences commercialisation partner, has launched Valeris Vantage, an operational intelligence platform designed to help patient support teams navigate complex healthcare programmes. The platform provides real-time guidance during patient interactions, surfacing programme-specific information, compliance prompts and workflow requirements as conversations unfold. Vantage uses AI to monitor conversations and deliver contextual support, helping case managers and nurses handle growing programme complexity whilst maintaining focus on patient care. The platform also provides comprehensive quality assurance, analysing 100% of interactions against compliance criteria. In a recent implementation with a specialty biopharmaceutical product, Vantage contributed to a 98.6% quality assurance score, zero patient safety errors and a 65% reduction in call errors. The platform aims to accelerate staff training, improve consistency and scale institutional knowledge across support programmes.

Valeris
Jun 16th, 2026
Valeris introduces Valeris Vantage(TM), combining real-time guidance and data insights to help patient support teams navigate complexity and improve outcomes.

Valeris introduces Valeris Vantage(TM), combining real-time guidance and data insights to help patient support teams navigate complexity and improve outcomes. June 16, 2026 Tuesday, June 16, 2026 JEFFERSONVILLE, IN and MORRISVILLE, NC - Valeris, a fully integrated life sciences commercialization partner, announced today the launch of Valeris Vantage(TM), a new Operational Intelligence Platform designed to help patient support teams navigate increasingly complex patient access and support programs with greater confidence, consistency, and efficiency. As part of Valeris's commitment to delivering industry-leading innovation, Vantage was developed to improve patient outcomes and experiences while driving measurable improvements in operational performance across the therapy journey.

PR Newswire
Apr 29th, 2026
Valeris and Fuze Health agree to collaborate on advancing A Connected and performance-driven Patient Access model.

Valeris and Fuze Health agree to collaborate on advancing A Connected and performance-driven Patient Access model. Apr 29, 2026, 10:00 ET Collaboration Aims to Accelerate Time to Therapy, Improve Patient Access, and Deliver Measurable Outcomes for Biopharmaceutical Partners JEFFERSONVILLE, Ind. and SAN FRANCISCO, April 29, 2026 /PRNewswire/ - Valeris, a fully integrated life sciences commercialization partner, and Fuze Health, a technology-powered health services company, have agreed to collaborate to modernize the patient access model by integrating digital pharmacy capabilities with access, affordability, and patient support services. The hub services leaders made the announcement at Asembia's AX26 Summit in Las Vegas. The collaboration reflects the companies' shared vision to transform market access in life sciences, powered by technology and data-driven insights that enable smarter strategies and better patient outcomes. Together, Valeris and Fuze Health aim to deliver a connected, efficient, and scalable model that improves speed, coordination, and performance across the patient journey. "At Valeris, our mission is to support patients every step of the way, making access to care faster, easier, and backed by unwavering support," said Robert Truckenmiller, Chief Executive Officer of Valeris. "This collaboration is a meaningful step toward that mission and our broader vision of bringing together digital pharmacy and patient access in an integrated model that reduces delays, improves coordination, and helps patients start and stay on therapy." "Fuze Health and Valeris share a commitment to expanding access to critical therapies and innovating the patient experience," said Paul Greenall, Chief Executive Officer of FuzeRx, the pharmacy services division of Fuze Health. "Together with Valeris, our goal is to deliver an augmented suite of solutions to ensure pharmaceutical manufacturers can enhance their provider and patient experiences." A Connected and Accountable Approach to Patient Access At the core of the collaboration is a coordinated operating model that brings together digital pharmacy workflows and patient access services into a unified, performance-driven experience. * Through its Access+ hub services platform, Fuze Health will lead digital pharmacy operations, including prescription intake, real-time eligibility and coverage checks, and patient engagement through automated, data-driven platforms. * Valeris will deliver comprehensive patient access services, including benefit verification across pharmacy and medical benefits, prior authorization and appeals support, affordability solutions, and patient support services. * Together, the organizations will streamline coordination across the patient journey, with greater visibility and accountability for patient outcomes. Delivering Measurable Impact Across Four Core Areas: Accelerating Time to Therapy: Faster benefit verification and streamlined prior authorization processes to reduce delays and improve turnaround times from prescription to therapy initiation. Improving Access, Affordability, and Outcomes: Integrated copay, affordability, and patient support services designed to reduce patient drop-off, increase therapy starts, and improve overall program performance. Delivering a Connected and Proactive Model: Tighter integration between digital pharmacy and patient services, combined with automation and AI to improve visibility, coordination, and speed at scale. Positioned for a Changing Market As the access landscape rapidly evolves, this collaboration aims to deliver operational performance and forward-looking innovation by combining digital enablement, data-driven insights, and patient-centric services to create a responsive and effective access model. About Valeris: Valeris is a fully integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company works on behalf of life sciences companies to improve the patient experience so that patients can access and adhere to critical medications. Backed by proven industry expertise, a deep commitment to patient care, the latest technology, and exceptionally talented team members, Valeris provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Valeris administers commercialization solutions for more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in Morrisville, North Carolina and Jeffersonville, Indiana. To learn more about Valeris, please visit www.valeris.com. About Fuze Health Fuze Health is a technology-powered healthcare solutions company dedicated to transforming patient experiences and enabling healthcare partners - including health plans, life sciences companies, employers and care providers - to excel in an outcomes-focused system. By connecting diagnostic and genomic testing, pharmacy services and care support, Fuze Health enables patients to access the care they need and healthcare partners to achieve better outcomes across the care journey. To learn more about Fuze Health, visit www.fuzehealth.com. Media Contacts Valeris: Landy Townsend VP, Marketing & Communications Valeris [email protected] SOURCE Valeris